The activation of IL6R was confirmed by an up-regulation of MMP-9 that is triggered by innate inflammatory mediators as extensively proven30, so that the inhibition of MMP-9 as therapeutic target for treatment of Dry Eye Syndrome, was recently suggested31. This evidence concerns the gene MMP9 and dry eye syndrome.